South Africa Diabetes Drugs and Devices Market Size (2024 - 2029)

South Africa Diabetes Drugs and Devices Market Analysis

South Africa's diabetes care drugs and devices market size was estimated at USD 0.47 billion in the current year. The market is expected to reach USD 0.55 billion in five years, registering a CAGR of more than 2% during the forecast period.

The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Africa. Patients with diabetes infected with COVID-19 may journey to improved blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in human beings with COVID-19 induced a good-sized increase in severity and mortality of COVID-19 in people with either kind 1 (T1DM) or kind two diabetes mellitus (T2DM), particularly in affiliation with terrible glycemic control. While new-onset hyperglycemia and new-onset diabetes (both T1DM and T2DM) have been increasingly diagnosed in the context of COVID-19 and have been associated with worse outcomes. A patient's blood glucose must be monitored and managed regularly to avoid aggravation.

According to IDF Diabetes Atlas 2022, one in nine adults in South Africa live with diabetes. The principal analysis for people living with diabetes is imbalances in blood glucose levels, which do not comply with the general blood glucose levels. The customary lab diagnostic tests can only help to diagnose the sickness by physicians. Patients with more fluctuations in glucose stages want to get it checked daily. Patients administering insulin must frequently test their blood glucose stages, adjust their insulin doses, or change the medication if necessary. The rate of newly diagnosed Type 1 and Type 2 diabetes cases is considered to increase, normally due to obesity, unhealthy diet, and bodily inactivity. The swiftly increasing incidence and incidence of diabetic sufferers and healthcare expenditure in developed international locations are warning signs of the growing usage of diabetic care products. Moreover, the growing adoption of insulin transport units and the rising incidence of diabetes is riding the market growth. Leading producers are focusing on technological innovations and developing superior products to acquire a sizeable market share.

Therefore, owing to the aforementioned factors, the studied market is anticipated to grow over the analysis period.

South Africa Diabetes Drugs and Devices Industry Segmentation

Patients with type 1 diabetes need to be given insulin because their pancreas cannot process it. To control blood glucose levels, insulin must be given various times daily. Some individuals with type 2 diabetes also have to take antidiabetic drugs. These drugs include diabetes medications and injections, for example, insulin. The South Africa diabetes care drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.